SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Cox Stephanie

(Last) (First) (Middle)
5599 SAN FELIPE, 17TH FLOOR

(Street)
HOUSTON TX 77056

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/05/2017
3. Issuer Name and Ticker or Trading Symbol
SCHLUMBERGER LIMITED/NV [ SLB ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President Human Resources
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $0.01 Par Value Per Share 2,711 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Incentive Stock Option (Right to Buy) (1) 01/17/2018 Common Stock, $0.01 Par Value Per Share 2,399 84.93 D
Incentive Stock Option (Right to Buy) (2) 01/22/2019 Common Stock, $0.01 Par Value Per Share 2,398 37.845 D
Incentive Stock Option (Right to Buy) (3) 04/23/2019 Common Stock, $0.01 Par Value Per Share 859 45.88 D
Incentive Stock Option (Right to Buy) (4) 01/21/2020 Common Stock, $0.01 Par Value Per Share 1,459 68.505 D
Incentive Stock Option (Right to Buy) (5) 01/20/2021 Common Stock, $0.01 Par Value Per Share 1,192 83.885 D
Incentive Stock Option (Right to Buy) (6) 01/19/2022 Common Stock, $0.01 Par Value Per Share 1,386 72.11 D
Incentive Stock Option (Right to Buy) 01/16/2019 01/16/2024 Common Stock, $0.01 Par Value Per Share 1,126 88.765 D
Incentive Stock Option (Right to Buy) 04/16/2020 04/16/2025 Common Stock, $0.01 Par Value Per Share 1,090 91.74 D
Incentive Stock Option (Right to Buy) 04/20/2021 04/20/2026 Common Stock, $0.01 Par Value Per Share 1,241 80.525 D
Incentive Stock Option (Right to Buy) (7) 01/19/2027 Common Stock, $0.01 Par Value Per Share 1,144 87.38 D
Non-Qualified Stock Option (Right to Buy) (8) 01/17/2018 Common Stock, $0.01 Par Value Per Share 2,601 84.93 D
Non-Qualified Stock Option (Right to Buy) (9) 01/22/2019 Common Stock, $0.01 Par Value Per Share 5,602 37.845 D
Non-Qualified Stock Option (Right to Buy) (10) 04/23/2019 Common Stock, $0.01 Par Value Per Share 49,141 45.88 D
Non-Qualified Stock Option (Right to Buy) (11) 01/21/2020 Common Stock, $0.01 Par Value Per Share 43,541 68.505 D
Non-Qualified Stock Option (Right to Buy) (12) 01/20/2021 Common Stock, $0.01 Par Value Per Share 48,808 83.885 D
Non-Qualified Stock Option (Right to Buy) (13) 01/19/2022 Common Stock, $0.01 Par Value Per Share 68,614 72.11 D
Non-Qualified Stock Option (Right to Buy) (14) 01/17/2023 Common Stock, $0.01 Par Value Per Share 40,635 73.25 D
Non-Qualified Stock Option (Right to Buy) (15) 01/16/2024 Common Stock, $0.01 Par Value Per Share 33,874 88.765 D
Non-Qualified Stock Option (Right to Buy) (16) 04/16/2025 Common Stock, $0.01 Par Value Per Share 22,910 91.74 D
Non-Qualified Stock Option (Right to Buy) (17) 04/20/2026 Common Stock, $0.01 Par Value Per Share 28,759 80.525 D
Non-Qualified Stock Option (Right to Buy) (18) 01/19/2027 Common Stock, $0.01 Par Value Per Share 13,856 87.38 D
RSU (Restricted Stock Unit) (19) (19) Common Stock, $0.01 Par Value Per Share 10,000 (20) D
RSU (Restricted Stock Unit) (21) (21) Common Stock, $0.01 Par Value Per Share 10,000 (20) D
RSU (Restricted Stock Unit) (22) (22) Common Stock, $0.01 Par Value Per Share 3,800 (20) D
Incentive Stock Option (Right to Buy) 01/17/2018 01/17/2023 Common Stock, $0.01 Par Value Per Share 1,365 73.25 D
Explanation of Responses:
1. This option became fully exercisable on January 17, 2013.
2. This option became fully exercisable on January 22, 2014.
3. This option became fully exercisable on April 23, 2014.
4. This option became fully exercisable on January 21, 2015.
5. This option became fully exercisable on January 20, 2016.
6. This option became fully exercisable on January 19, 2017.
7. This option is exercisable in five equal annual installments beginning on January 19, 2018.
8. This option became fully exercisable on January 17, 2013.
9. This option became fully exercisable on January 22, 2014.
10. This option became fully exercisable on April 23, 2014.
11. This option became fully exercisable on January 21, 2015.
12. This option became fully exercisable on January 20, 2016.
13. This option became fully exercisable on January 19, 2017.
14. This option is exercisable in five equal annual installments beginning on January 17, 2014.
15. This option is exercisable in five equal annual installments beginning on January 16, 2015.
16. This option is exercisable in five equal annual installments beginning on April 16, 2016.
17. This option is exercisable in five equal annual installments beginning on April 20, 2017.
18. This option is exercisable in five equal annual installments beginning on January 19, 2018.
19. The restricted stock unit award was granted July 17, 2014 and vests 100% on July 17, 2017.
20. Each restricted stock unit award represents the right to receive, at settlement, one (1) share of common stock
21. The restricted stock unit award was granted July 20, 2016 and vests 100% on July 20, 2019.
22. The restricted stock unit award was granted July 19, 2017 and vests 100% on July 19, 2020.
/s/ Matthew Rinegar, Attorney-in-Fact 06/13/2017
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
SCHLUMBERGER LIMITED POWER OF ATTORNEY

       The undersigned, in her capacity as a director or
officer, or both, of Schlumberger Limited, a Curacao
corporation (the "Company"), does hereby appoint each of
Saul Laureles, Matthew Rinegar and Grace Holmes, or either
any of them acting singly, his true and lawful attorney-
in-fact with full power of substitution, to (a) prepare,
execute in the undersigneds name and on the undersigneds
behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments
thereto, and any other documents necessary or appropriate
to obtain codes, passwords and passphrases enabling the
undersigned to make electronic filings with the SEC
of reports required by Section 16(a) of the Securities
Exchange Act of 1934, as amended (the Exchange Act), or
any rule or regulation of the SEC; and (b) execute for
and on behalf of the undersigned, in the undersigneds
capacity as a director or officer, or both, of the Company,
Forms 3, 4 and 5 in accordance with Section 16 of the
Exchange Act, as well as Forms 144, and complete and
execute any amendment or amendments thereto, and to file
the same or cause the same to be filed with the SEC.
       This Power of Attorney supersedes any and all
prior and existing powers of attorney signed by the
undersigned with respect to the subject matter hereof, and
shall remain in full force and effect until the undersigned
is no longer required to file Forms 3, 4, 5 or 144 with
respect to the undersigneds holdings of and transactions
in securities issued by the Company, unless earlier revoked
by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

June 12, 2017

/s/ Stephanie Cox
Stephanie Cox